Medicus Sciences Acquisition Corp.
Status: Liquidated
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $92.00M |
|---|---|
| IPO Date | Feb 16, 2021 |
| CEO | Michael Castor, M.D. |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Medical technology |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Feb 21, 2023 |
MSAC
MSACU
MSACW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Medicus Sciences Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 11 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jacob Gottlieb, M.D. | 49 | Executive Chairman |
| Michael Castor, M.D. | 49 | Chief Executive Officer & Director |
| Neil Puri | Chief Business Officer | |
| Judah Drillick | 44 | Chief Financial Officer |
| Kenneth Berkovitz, M.D., F.A.C.C. | 46 | Director |
| Christopher Kaster | 49 | Director |
| Ross Levine, M.D. | 48 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Maxim | BR | 8,000,000 | units |
| 8,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 2.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 11 filings.